Literature DB >> 25894310

Elevated follicular helper T cells and expression of IL-21 in thyroid tissues are involved in the pathogenesis of Graves' disease.

Jin Zhang1, Meng Ren, Hua Zeng, Ying Guo, Zhenwu Zhuang, Zhimei Feng, Haiyan Yan, Mingtong Xu, Weiwen Liang, Chuan Yang, Hua Cheng, Helin Ding, Li Yan.   

Abstract

The follicular helper T cell (Tfh) and IL-21 have been shown to play an important role in many autoimmune diseases. However, less is known about their role in Graves' disease (GD). This study aimed to investigate the expression of Tfhs and related factors (IL-21, IL-21R, CXCR5, and CXCL13) in GD thyroid tissues and to explore the effect of IL-21 on thyroid follicular cells (TFCs). The expression of Tfh-related factors in GD and normal thyroid tissues was validated using immunohistochemistry, real-time polymerase chain reaction and Western blotting. Confocal microscopy confirmed the presence of Tfh and IL-21R on CD4(+)T-/CD19(+)B cell in GD thyroid tissues. Furthermore, the effect of IL-21 on cAMP production in TFCs upon thyroid-stimulating antibody (TSAb) stimulation was also examined by an in vitro bioassay. The increased expression of Tfh-related factors was observed in GD thyroid tissues compared to control subjects. Confocal microscopy further confirmed the presence of Tfhs and the expression of IL-21R on CD4(+)T cells and CD19(+)B cells in GD thyroid tissues. Moreover, the expression of IL-21mRNA in GD thyroid tissues was correlated with the levels of thyroid autoantibodies. Additionally, IL-21 could indirectly promote cAMP production upon TSAb stimulation in TFCs when cooperating with lymphocytes, and GD TFCs were more sensitive to IL-21 stimulation than normal TFCs. There is increased expression of Tfhs and related factors (IL-21, IL-21R, CXCR5, and CXCL13) in GD thyroid tissues, and the expression of IL-21mRNA in GD thyroid tissues was found to correlate with the serum levels of thyroid autoantibodies and thyroid hormones. Moreover, IL-21 could indirectly enhance the biological activity of TFCs upon TSAb stimulation when cooperating with lymphocytes in vitro, particularly in GD TFCs, suggesting that Tfh and IL-21 might be involved in the pathogenesis of GD.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25894310     DOI: 10.1007/s12026-015-8647-z

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  39 in total

1.  Graves' disease and Hashimoto's thyroiditis in monozygotic twins: case study as well as transcriptomic and immunohistological analysis of thyroid tissues.

Authors:  G Aust; K Krohn; N G Morgenthaler; S Schröder; A Schütz; J Edelmann; E Brylla
Journal:  Eur J Endocrinol       Date:  2006-01       Impact factor: 6.664

2.  Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration.

Authors:  Stefan Kuchen; Rachel Robbins; Gary P Sims; Chen Sheng; Terence M Phillips; Peter E Lipsky; Rachel Ettinger
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

Review 3.  T follicular helper (TFH) cells in normal and dysregulated immune responses.

Authors:  Cecile King; Stuart G Tangye; Charles R Mackay
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

Review 4.  Cytokines, Graves' disease, and thyroid-associated ophthalmopathy.

Authors:  Andrew G Gianoukakis; Nicole Khadavi; Terry J Smith
Journal:  Thyroid       Date:  2008-09       Impact factor: 6.568

5.  T cell-derived leptin contributes to increased frequency of T helper type 17 cells in female patients with Hashimoto's thyroiditis.

Authors:  S Wang; S E Baidoo; Y Liu; C Zhu; J Tian; J Ma; J Tong; J Chen; X Tang; H Xu; L Lu
Journal:  Clin Exp Immunol       Date:  2013-01       Impact factor: 4.330

6.  IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells.

Authors:  Rachel Ettinger; Gary P Sims; Anna-Marie Fairhurst; Rachel Robbins; Yong Sing da Silva; Rosanne Spolski; Warren J Leonard; Peter E Lipsky
Journal:  J Immunol       Date:  2005-12-15       Impact factor: 5.422

7.  Cutting edge: IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells.

Authors:  Jérôme Pène; Jean-François Gauchat; Sandrine Lécart; Elodie Drouet; Paul Guglielmi; Vera Boulay; Adriana Delwail; Don Foster; Jean-Claude Lecron; Hans Yssel
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

8.  Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages.

Authors:  Roza I Nurieva; Yeonseok Chung; Daehee Hwang; Xuexian O Yang; Hong Soon Kang; Li Ma; Yi-hong Wang; Stephanie S Watowich; Anton M Jetten; Qiang Tian; Chen Dong
Journal:  Immunity       Date:  2008-07-03       Impact factor: 31.745

9.  Interleukin 21 correlates with T cell and B cell subset alterations in systemic lupus erythematosus.

Authors:  Benjamin Terrier; Nathalie Costedoat-Chalumeau; Marlène Garrido; Guillaume Geri; Michelle Rosenzwajg; Lucile Musset; David Klatzmann; David Saadoun; Patrice Cacoub
Journal:  J Rheumatol       Date:  2012-08-01       Impact factor: 4.666

10.  Polymorphisms of interleukin-21 and interleukin-21-receptor genes confer risk for autoimmune thyroid diseases.

Authors:  Jian Zhang; Wan Xia Xiao; Yuan Feng Zhu; Fatuma Said Muhali; Ling Xiao; Wen Juan Jiang; Xiao Hong Shi; Lian Hua Zhou; Jin An Zhang
Journal:  BMC Endocr Disord       Date:  2013-07-29       Impact factor: 2.763

View more
  9 in total

1.  The Role of Integrin Expressing Cells in Modulating Disease Susceptibility and Progression (January 2016).

Authors:  Aftab A Ansari; Siddappa N Byrareddy
Journal:  Int Trends Immun       Date:  2016-01

Review 2.  T Follicular Helper Cells in Autoimmune Disorders.

Authors:  Noémie Gensous; Manon Charrier; Dorothée Duluc; Cécile Contin-Bordes; Marie-Elise Truchetet; Estibaliz Lazaro; Pierre Duffau; Patrick Blanco; Christophe Richez
Journal:  Front Immunol       Date:  2018-07-17       Impact factor: 7.561

3.  Constitutive Changes in Circulating Follicular Helper T Cells and Their Subsets in Patients with Graves' Disease.

Authors:  Yan Liu; Xinwang Yuan; Xiaofang Li; Dawei Cui; Jue Xie
Journal:  J Immunol Res       Date:  2018-12-24       Impact factor: 4.818

4.  Increased Human Interleukin-32 Expression Is Related to Disease Activity of Graves' Disease.

Authors:  Qiuming Yao; Bin Wang; Xi Jia; Qian Li; Wei Yao; Jin-An Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2019-09-26       Impact factor: 5.555

Review 5.  The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition.

Authors:  Gilda Varricchi; Stefania Loffredo; Giancarlo Marone; Luca Modestino; Poupak Fallahi; Silvia Martina Ferrari; Amato de Paulis; Alessandro Antonelli; Maria Rosaria Galdiero
Journal:  Int J Mol Sci       Date:  2019-08-13       Impact factor: 5.923

6.  Tissue Infiltrating LTi-Like Group 3 Innate Lymphoid Cells and T Follicular Helper Cells in Graves' and Hashimoto's Thyroiditis.

Authors:  Audrey Mohr; Christophe Trésallet; Natacha Monot; Adeline Bauvois; Delphine Abiven; Muhammad Atif; Laetitia Claër; Rajneesh Malhotra; Gaëll Mayer; Robert Balderas; Outi Vaarala; Gabrielle Deniziaut; Isabelle Brocheriou; Camille Buffet; Laurence Leenhardt; Guy Gorochov; Makoto Miyara
Journal:  Front Immunol       Date:  2020-04-09       Impact factor: 7.561

Review 7.  Cytokines that Modulate the Differentiation of Th17 Cells in Autoimmune Uveitis.

Authors:  Kailei Guo; Xiaomin Zhang
Journal:  J Immunol Res       Date:  2021-03-16       Impact factor: 4.818

Review 8.  Role of the CXCL13/CXCR5 Axis in Autoimmune Diseases.

Authors:  Zijian Pan; Tong Zhu; Yanjun Liu; Nannan Zhang
Journal:  Front Immunol       Date:  2022-03-04       Impact factor: 7.561

Review 9.  Genetics, Epigenetics, Cellular Immunology, and Gut Microbiota: Emerging Links With Graves' Disease.

Authors:  Fangyu Zhou; Xin Wang; Lingjun Wang; Xin Sun; Guiqin Tan; Wenwen Wei; Guangbing Zheng; Xiaomin Ma; Dan Tian; Hongsong Yu
Journal:  Front Cell Dev Biol       Date:  2022-01-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.